Your browser doesn't support javascript.
loading
First successful case of platinum-based chemotherapy for neuroendocrine prostate cancer with BRCA2 and PTEN alterations.
Omura, Minami; Kosaka, Takeo; Aimono, Eriko; Nakamura, Kohei; Hongo, Hiroshi; Mikami, Shuji; Nishihara, Hiroshi; Oya, Mototsugu.
Affiliation
  • Omura M; Department of Urology Keio University School of Medicine Tokyo Japan.
  • Kosaka T; Department of Urology Keio University School of Medicine Tokyo Japan.
  • Aimono E; Genomics Unit Keio Cancer Center Keio University School of Medicine Tokyo Japan.
  • Nakamura K; Genomics Unit Keio Cancer Center Keio University School of Medicine Tokyo Japan.
  • Hongo H; Department of Urology Keio University School of Medicine Tokyo Japan.
  • Mikami S; Division of Diagnostic Pathology Keio University Hospital Tokyo Japan.
  • Nishihara H; Genomics Unit Keio Cancer Center Keio University School of Medicine Tokyo Japan.
  • Oya M; Department of Urology Keio University School of Medicine Tokyo Japan.
IJU Case Rep ; 5(1): 41-44, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35005470
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: IJU Case Rep Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: IJU Case Rep Year: 2022 Document type: Article